Suzhou Forlong Biotechnology Co., Ltd
Suzhou Forlong Biotechnology Co., Ltd
Explore linked clinical trials.4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Subcutaneous FL115 Monotherapy in Participants With Advanced Solid Tumors | Advanced Solid Tumours | Not yet recruiting | Phase 1 | 2026-08-26 | NCT07785193 | |
| A Study of FL115 in Combination With a PD-1 Antibody in Advanced Solid Tumors | Advanced Solid Tumors | Recruiting | Phase 1 / Phase 2 | 2026-01-08 | NCT07131202 | |
| A Study of FL115 Monotherapy in Unresectable or Metastatic Solid Tumors | Locally Advanced/Metastatic Solid Tumors | Active, not recruiting | Phase 1 | 2026-01-08 | NCT07131189 | |
| A Study of Intravesical FL115 Alone or in Combination With BCG in Non-Muscle Invasive Bladder Cancer | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Non-Muscle Invasive Bladder Neoplasms, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, carcinoma, epithelial neoplasm, neoplasm, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder | Recruiting | Phase 1 / Phase 2 | 2025-08-14 | NCT07122414 |